Variant report

Variant	nsv898952
Chromosome Location	chr12:29565537-29617550
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:457)
CpG islands
(count:122)
Chromatin interactive
region (count:6)
LncRNA
region (count:7)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:457 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr12:29590404-29590811	HepG2	liver:	n/a	n/a
2	ATF1	chr12:29581667-29581980	K562	blood:	n/a	n/a
3	ATF1	chr12:29588530-29588845	K562	blood:	n/a	n/a
4	ATF2	chr12:29581583-29582056	GM12878	blood:	n/a	n/a
5	ATF3	chr12:29581552-29582134	HCT-116	colon:	n/a	n/a
6	BATF	chr12:29581664-29581970	GM12878	blood:	n/a	chr12:29581803-29581814
7	BCL3	chr12:29581711-29581989	GM12878	blood:	n/a	chr12:29581807-29581816
8	BDP1	chr12:29581674-29582096	Hela-S3	cervix:	n/a	n/a
9	BHLHE40	chr12:29576464-29576511	K562	blood:	n/a	n/a
10	BHLHE40	chr12:29580984-29581302	GM12878	blood:	n/a	n/a
11	BHLHE40	chr12:29574007-29574030	K562	blood:	n/a	n/a
12	BHLHE40	chr12:29580970-29581287	K562	blood:	n/a	n/a
13	BRCA1	chr12:29583383-29583533	Hela-S3	cervix:	n/a	n/a
14	CBX3	chr12:29581479-29582146	HCT-116	colon:	n/a	n/a
15	CEBPB	chr12:29581379-29582148	HCT-116	colon:	n/a	n/a
16	CEBPB	chr12:29567360-29567632	IMR90	lung:	n/a	n/a
17	CEBPB	chr12:29587977-29588177	K562	blood:	n/a	n/a
18	CEBPB	chr12:29586466-29586666	K562	blood:	n/a	n/a
19	CEBPB	chr12:29581659-29581848	K562	blood:	n/a	n/a
20	CEBPB	chr12:29608874-29609074	K562	blood:	n/a	chr12:29609017-29609026 chr12:29609017-29609028
21	CEBPB	chr12:29581604-29582117	ECC-1	luminal epithelium:	n/a	n/a
22	CEBPB	chr12:29581616-29581936	HepG2	liver:	n/a	n/a
23	CEBPB	chr12:29582868-29583697	Hela-S3	cervix:	n/a	chr12:29582868-29582880
24	CEBPB	chr12:29581449-29582118	HCT-116	colon:	n/a	n/a
25	CEBPB	chr12:29581577-29581987	IMR90	lung:	n/a	n/a
26	CEBPB	chr12:29588524-29588820	K562	blood:	n/a	chr12:29588670-29588683
27	CEBPB	chr12:29581592-29581925	K562	blood:	n/a	n/a
28	CEBPB	chr12:29581581-29582039	ECC-1	luminal epithelium:	n/a	n/a
29	CEBPB	chr12:29567318-29567644	ECC-1	luminal epithelium:	n/a	n/a
30	CEBPB	chr12:29581048-29582065	Hela-S3	cervix:	n/a	n/a
31	CEBPB	chr12:29586435-29586575	HepG2	liver:	n/a	n/a
32	CEBPB	chr12:29588612-29588812	H1-hESC	embryonic stem cell:	n/a	chr12:29588670-29588683
33	CEBPB	chr12:29588569-29588839	HepG2	liver:	n/a	chr12:29588670-29588683
34	CEBPB	chr12:29581591-29581924	K562	blood:	n/a	n/a
35	CHD1	chr12:29581054-29581200	GM12878	blood:	n/a	n/a
36	CHD2	chr12:29580921-29581414	GM12878	blood:	n/a	n/a
37	CHD2	chr12:29581533-29582044	Hela-S3	cervix:	n/a	n/a
38	CHD2	chr12:29583235-29583652	Hela-S3	cervix:	n/a	n/a
39	CTCF	chr12:29581040-29581190	BE2_C	brain:	n/a	n/a
40	CTCF	chr12:29581020-29581170	Caco-2	colon:	n/a	n/a
41	CTCF	chr12:29580813-29581327	K562	blood:	n/a	n/a
42	CTCF	chr12:29581060-29581210	AG04449	skin:	n/a	n/a
43	CTCF	chr12:29581040-29581190	SK-N-SH_RA	brain:	n/a	n/a
44	CTCF	chr12:29581040-29581194	Hela-S3	cervix:	n/a	n/a
45	CTCF	chr12:29581060-29581210	GM12864	blood:	n/a	n/a
46	CTCF	chr12:29581063-29581178	Spleen_OC	spleen:	n/a	n/a
47	CTCF	chr12:29580400-29580550	GM12873	blood:	n/a	n/a
48	CTCF	chr12:29581080-29581133	HUVEC	blood vessel:	n/a	n/a
49	CTCF	chr12:29581080-29581230	GM12867	blood:	n/a	n/a
50	CTCF	chr12:29581040-29581190	HVMF	connective:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr12:29581042-29581092	Caco-2	colon:	n/a
2	chr12:29581042-29581092	AoSMC	blood vessel:	n/a
3	chr12:29581042-29581092	HMEC	breast:	n/a
4	chr12:29581042-29581092	GM12892	blood:	n/a
5	chr12:29581042-29581092	SAEC	small airway:	n/a
6	chr12:29568207-29568257	HCPEpiC	choroid plexus:	n/a
7	chr12:29568207-29568257	NHBE	bronchial:	n/a
8	chr12:29568207-29568257	PANC-1	pancreas:	n/a
9	chr12:29581042-29581092	HL-60	blood:	n/a
10	chr12:29568207-29568257	HRCEpiC	kidney:	n/a
11	chr12:29581042-29581092	GM19239	blood:	n/a
12	chr12:29581042-29581092	Hela-S3	cervix:	n/a
13	chr12:29581042-29581092	BE2_C	brain:	n/a
14	chr12:29581042-29581092	HCT-116	colon:	n/a
15	chr12:29568207-29568257	A549	lung:	n/a
16	chr12:29581042-29581092	GM12878	blood:	n/a
17	chr12:29568207-29568257	H1-hESC	embryonic stem cell:	embryo
18	chr12:29581042-29581092	HRE	kidney:	n/a
19	chr12:29581042-29581092	AG04449	skin:	fetal
20	chr12:29581042-29581092	RPTEC	kidney:	n/a
21	chr12:29581042-29581092	NH-A	brain:	n/a
22	chr12:29568207-29568257	RPTEC	kidney:	n/a
23	chr12:29568207-29568257	HRE	kidney:	n/a
24	chr12:29568207-29568257	GM19239	blood:	n/a
25	chr12:29568207-29568257	Hepatocyte	liver:	n/a
26	chr12:29568207-29568257	AG09309	skin:	n/a
27	chr12:29568207-29568257	BJ	skin:	n/a
28	chr12:29581042-29581092	A549	lung:	n/a
29	chr12:29581042-29581092	ECC-1	luminal epithelium:	n/a
30	chr12:29568207-29568257	AG04450	lung:	fetal
31	chr12:29568207-29568257	Hela-S3	cervix:	n/a
32	chr12:29568207-29568257	SK-N-MC	brain:	n/a
33	chr12:29581042-29581092	HRPEpiC	eye:	n/a
34	chr12:29581042-29581092	PANC-1	pancreas:	n/a
35	chr12:29568207-29568257	HCM	heart:	n/a
36	chr12:29568207-29568257	AoSMC	blood vessel:	n/a
37	chr12:29581042-29581092	PrEC	prostate:	n/a
38	chr12:29568207-29568257	NB4	blood:	n/a
39	chr12:29581042-29581092	IMR90	lung:	fetal
40	chr12:29581042-29581092	HEK293	kidney:	embryo
41	chr12:29581042-29581092	NB4	blood:	n/a
42	chr12:29568207-29568257	NH-A	brain:	n/a
43	chr12:29581042-29581092	PFSK-1	brain:	n/a
44	chr12:29581042-29581092	MCF10A-Er-Src	breast:	n/a
45	chr12:29581042-29581092	HIPEpiC	eye:	n/a
46	chr12:29568207-29568257	HCT-116	colon:	n/a
47	chr12:29568207-29568257	MCF-7	breast:	n/a
48	chr12:29568207-29568257	GM12891	blood:	n/a
49	chr12:29568207-29568257	SK-N-SH_RA	brain:	n/a
50	chr12:29568207-29568257	HAEpiC	amniotic membrane:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:29570616..29572170-chr12:29576481..29578038,2	K562	blood:
2	chr1:228327057..228327822-chr12:29588102..29589082,2	NB4	blood:
3	chr12:29581032..29583088-chr12:29583675..29586348,2	K562	blood:
4	chr12:29570616..29572170-chr12:29576481..29578038,2	K562	blood:
5	chr12:29540594..29543484-chr12:29574878..29577697,2	K562	blood:
6	chr12:29581032..29583088-chr12:29583675..29586348,2	K562	blood:

(count:7 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-RP11-677C1.2.1-2	chr12:29614729-29614867	NONHSAT027489
2	lnc-RP11-677C1.2.1-2	chr12:29617338-29617863	NONHSAT027489
3	lnc-RP11-677C1.2.1-2	chr12:29578858-29578997	NONHSAT027492
4	lnc-ERGIC2-1	chr12:29565419-29565658	XLOC_010039
5	lnc-RP11-677C1.2.1-2	chr12:29614667-29614867	NR_073170
6	lnc-ERGIC2-1	chr12:29573270-29573303	XLOC_010039
7	lnc-RP11-677C1.2.1-2	chr12:29617338-29617863	NR_073170

No data

Variant related genes	Relation type
OVCH1-AS1	TF binding region
OVCH1	TF binding region
OVCH1-AS1	CpG island
OVCH1	CpG island
ENSG00000143774	chromatin interactions
ENSG00000257599	chromatin interactions

Extended variants
information (count: 1852 )
Associated
traits (count: 60 )

Variant overlapped rSNPs/rCNVs (count:1852 , 50 per page) page: 1 2 3 4 5 6 7 ... 38

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1436321	chr12:29565537-29565538	Inactive region	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs189168100	chr12:29565569-29565570	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
3	rs117886897	chr12:29565580-29565581	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
4	rs373034674	chr12:29565588-29565589	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
5	rs73276814	chr12:29565590-29565591	Inactive region	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs549309367	chr12:29565618-29565619	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
7	rs34556159	chr12:29565629-29565630	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
8	rs182594022	chr12:29565630-29565631	Inactive region	lncRNA	n/a	Overlapped CNVs	n/a
9	rs139873706	chr12:29567017-29567018	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs143225688	chr12:29567021-29567022	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs10771529	chr12:29567022-29567023	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
12	rs186413302	chr12:29567026-29567027	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs548018447	chr12:29567054-29567055	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs566131263	chr12:29567095-29567096	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs10771530	chr12:29567148-29567149	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
16	rs149967470	chr12:29567207-29567208	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs539253251	chr12:29567276-29567277	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs73276818	chr12:29567278-29567279	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs117515437	chr12:29567287-29567288	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs7963652	chr12:29567293-29567294	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
21	rs552797717	chr12:29567316-29567317	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs7978770	chr12:29567345-29567346	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
23	rs145072748	chr12:29567390-29567391	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs190263973	chr12:29567391-29567392	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs576452191	chr12:29567421-29567422	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs543839345	chr12:29567446-29567447	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs11837482	chr12:29567458-29567459	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs56008322	chr12:29567552-29567553	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs76416033	chr12:29567631-29567632	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs11837535	chr12:29567663-29567664	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs11050226	chr12:29567676-29567677	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs542593294	chr12:29567678-29567679	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs530215729	chr12:29567691-29567692	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs182133133	chr12:29567716-29567717	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs563240928	chr12:29567737-29567738	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs577763338	chr12:29567754-29567755	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs530483884	chr12:29567809-29567810	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs34822853	chr12:29567953-29567954	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs71043001	chr12:29567954-29567955	Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs568148680	chr12:29567978-29567979	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs551798592	chr12:29567979-29567980	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs56808425	chr12:29567981-29567982	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
43	rs1436318	chr12:29568005-29568006	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
44	rs575800636	chr12:29568006-29568007	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs1436317	chr12:29568029-29568030	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
46	rs185482900	chr12:29568104-29568105	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs376286391	chr12:29568113-29568114	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs79729808	chr12:29568136-29568137	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs557069990	chr12:29568162-29568163	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs79848989	chr12:29568174-29568175	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:60)

Disease	PMID	Source
Melanoma	18172304	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Myxofibrosarcoma	16751306	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Wilms tumour	21544195	CNVD
Squamous cell cancer	21044232	CNVD
Acute myeloid leukemia	16864856	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Colorectal cancer	20709793	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Testicular cancer	18059402	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Seminomas	18059402	CNVD
Esophageal cancer	21851588	CNVD
Lung cancer	20668451	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Testicular germ cell tumor	18059402	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Basal cell lymphoma	17053054	CNVD
Chronic lymphocytic leukemia	21670202	CNVD
Ewing''s sarcoma	17952124	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Breast cancer	21858162	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Myelodysplastic syndrome	21251322	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Autism	22495311	CNVD
Cancer	20164919	CNVD
Acute myeloid leukemia	21251322	CNVD
Acute myeloid leukemia	20729466	CNVD
small cell lung cancer	20016488	CNVD
Neurodevelopmental disorder	22521361	CNVD
Breast cancer	21509527	CNVD
Autism	22102821	CNVD
Follicular lymphoma	18703704	CNVD
Lung cancer	18438408	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Breast cancer	17133270	CNVD
Cancer	21129771	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	17899364	CNVD
Myelofibrosis	22110671	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Intellectual disability	21811512	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:173 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr12:29567000-29567200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
2	chr12:29567200-29567800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
3	chr12:29567200-29568600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
4	chr12:29567800-29568400	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
5	chr12:29568400-29569800	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
6	chr12:29570000-29570200	Enhancers	IMR90 fetal lung fibroblasts Cell Line	lung
7	chr12:29570800-29571000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
8	chr12:29571000-29571200	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
9	chr12:29571000-29583400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
10	chr12:29578000-29583200	Enhancers	Hela-S3	cervix
11	chr12:29578200-29580000	Enhancers	HUVEC	blood vessel
12	chr12:29578400-29579000	Enhancers	HMEC	breast
13	chr12:29578400-29579200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
14	chr12:29578400-29579200	Enhancers	Muscle Satellite Cultured Cells	--
15	chr12:29578400-29579400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
16	chr12:29578600-29579000	Enhancers	NHEK	skin
17	chr12:29578600-29579600	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
18	chr12:29579000-29581200	Weak transcription	HMEC	breast
19	chr12:29579000-29581400	Weak transcription	NHEK	skin
20	chr12:29579200-29581200	Weak transcription	Muscle Satellite Cultured Cells	--
21	chr12:29579400-29581200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
22	chr12:29579600-29581400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
23	chr12:29579800-29580800	Enhancers	Monocytes-CD14+_RO01746	blood
24	chr12:29579800-29583800	Enhancers	Primary monocytes fromperipheralblood	blood
25	chr12:29580000-29581400	Weak transcription	HUVEC	blood vessel
26	chr12:29580000-29583400	Enhancers	Primary neutrophils fromperipheralblood	blood
27	chr12:29580400-29581200	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
28	chr12:29580400-29582000	Enhancers	GM12878-XiMat	blood
29	chr12:29580800-29581400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
30	chr12:29580800-29581600	Enhancers	K562	blood
31	chr12:29580800-29581800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
32	chr12:29580800-29582200	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
33	chr12:29581200-29581600	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
34	chr12:29581200-29581600	Enhancers	HSMMtube	muscle
35	chr12:29581200-29581800	Enhancers	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
36	chr12:29581200-29581800	Enhancers	Muscle Satellite Cultured Cells	--
37	chr12:29581200-29582400	Enhancers	HMEC	breast
38	chr12:29581200-29583800	Enhancers	Duodenum Mucosa	Duodenum
39	chr12:29581400-29581800	Enhancers	HUVEC	blood vessel
40	chr12:29581400-29582000	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
41	chr12:29581400-29582400	Enhancers	NHEK	skin
42	chr12:29581400-29582600	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
43	chr12:29581400-29584000	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
44	chr12:29581600-29581800	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
45	chr12:29581600-29581800	Enhancers	Liver	Liver
46	chr12:29581600-29583200	Weak transcription	K562	blood
47	chr12:29581600-29604200	Weak transcription	HSMMtube	muscle
48	chr12:29581800-29583000	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
49	chr12:29581800-29613600	Weak transcription	Muscle Satellite Cultured Cells	--
50	chr12:29582200-29583600	Enhancers	Monocytes-CD14+_RO01746	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links